Professional Healthcare INC
Professional Healthcare INC was paid $4.91M by Medicaid between Jun 2022 and Sep 2024, across 18 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 57% of everything it billed.
ROLLING MEADOWS, IL 60008
Next to other Clinical Medical Laboratory providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 81,140 | $3.38M | |
| 2023 | 40,045 | $1.51M | |
| 2024incomplete | 1,509 | $19K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 57% | 39,125 | 7,350 | $2.79M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 18% | 37,516 | 7,411 | $884K |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 14% | 29,682 | 6,604 | $703K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 9.7% | 13,510 | 3,771 | $478K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 745 | 257 | $38K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 82 | 59 | $8K |
| 80053 | Comprehensive metabolic panel | <1% | 373 | 307 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 366 | 292 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 41 | 16 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 77 | 64 | $1K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 380 | 120 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 112 | 99 | $895.81 |
6 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.